India  

Two indigenous Indian vaccines cleared to start human trials, each has 1,000 volunteers

DNA Tuesday, 14 July 2020
India is perceived and is an important player in the global vaccine supply, fast-tracking COVID-19 vaccine development is a moral duty, ICMR chief Balram Bhargava said.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Recovered Covid patients outnumber active cases; Govt gives vaccine updates

Recovered Covid patients outnumber active cases; Govt gives vaccine updates 12:38

Health Ministry and ICMR briefed on the Covid-19 situation in India. Health Ministry’s Rajesh Bhushan said the number of recovered patients in India outnumbers active Covid-19 cases. The growth rate of Covid cases in India has now reduced to 3.24 %. ICMR said India is working on two indigenous...

💡 newsR Knowledge: Other News Mentions

Balram Bhargava Indian science administrator

'5-T' strategy is to adhere to mitigate COVID-19: ICMR DG [Video]

'5-T' strategy is to adhere to mitigate COVID-19: ICMR DG

Indian Council of Medical Research Director General Balram Bhargava on September 29 said that 5-T strategy (Test, Track, Trace, Treat and Technology is to adhered to contain spread of COVID-19. "Since a large portion of the population is yet susceptible, prevention fatigue is to be avoided and 5-T strategy (Test, Track, Trace, Treat and Technology) is to be adhered," said Bhargava on Second Sero-survey.

Credit: ANI    Duration: 01:32Published
Urban slum, urban non-slum had higher SARS_CoV_2 infection prevalence than rural areas: ICMR [Video]

Urban slum, urban non-slum had higher SARS_CoV_2 infection prevalence than rural areas: ICMR

Indian Council of Medical Research Director General Balram Bhargava on September 29 said that urban slum and urban non-slum areas had higher SARS_CoV_2 infection prevalence than that of rural areas. "As per ICMR's (Indian Council of Medical Research) second sero survey report, urban slum and urban non-slum areas had higher SARS_CoV_2 infection prevalence than that of rural areas," Bhargava added.

Credit: ANI    Duration: 01:17Published

‘No vaccine for respiratory diseases has 100% efficacy’

No vaccine for respiratory diseases has a 100% efficacy and ones with a 50-100% efficacy may be approved for use against the Covid-19 pandemic, Indian Council..
IndiaTimes
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon [Video]

Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon

Director General of the Indian Council of Medical Research (ICMR), Dr Balram Bhargava said three vaccine candidates are at different clinical trial stages in India. Covid-19 vaccine candidates being manufactured by Cadila Healthcare and Bharat Biotech have completed the first phase of the trial while the Serum Institute of India (SII) will begin with Phase 3 trial after getting the nod, Balram Bhargava, ICMR’s director general, said during the health ministry’s briefing.The Pune-based Serum Institute will conduct the Phase 3 trial on 1,500 volunteers across 14 locations, Bhargava added.

Credit: HT Digital Content    Duration: 01:19Published

Indian Council of Medical Research Indian Council of Medical Research organization

India's considerable population still vulnerable to COVID-19: ICMR's 2nd Sero Survey [Video]

India's considerable population still vulnerable to COVID-19: ICMR's 2nd Sero Survey

Indian Council of Medical Research second Sero Survey report revealed that considerable population still vulnerable to COVID-19, said Health Ministry Secretary Rajesh Bhushan on September 29. "ICMR's (Indian Council of Medical Research) second Sero Survey report reveals that a considerable population still vulnerable to COVID-19," said Bhushan.

Credit: ANI    Duration: 01:27Published

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Fresh ally trouble for BJP? LJP leader says Chirag Paswan CM face | Bihar polls [Video]

Fresh ally trouble for BJP? LJP leader says Chirag Paswan CM face | Bihar polls

Compounding alliance troubles for the Bharatiya Janata Party, a leader of the Lok Janshakti Party said that Chirag Paswan is the outfit's Chief Ministerial face for Bihar. The comment was made weeks before the state goes to polls. LJP is a constituent of the National Democratic Alliance which is currently in power in the state. The other members are BJP and the Janata Dal (United), and they have already declared that incumbent CM Nitish Kumar will continue to lead the alliance in the state. The NDA is yet to conclude seat-sharing talks, as well. Bihar will vote in 3 phases to choose MLAs to the 243-seat Assembly. Voting will be held on October 28, November 3 and 7 in the shadow of the ongoing Covid-19 pandemic. Results of the elections will be announced by the Election Commission on November 10, 2020.

Credit: HT Digital Content    Duration: 02:27Published
1 mln COVID-19 deaths "a very sad milestone"- WHO [Video]

1 mln COVID-19 deaths "a very sad milestone"- WHO

The World Health Organization said on Tuesday that one million deaths from COVID-19 was "a very sad milestone", after many victims suffered "a terribly difficult and lonely death" and their families were unable to say goodbye.

Credit: Reuters Studio    Duration: 00:52Published

You Might Like


Related videos from verified sources

Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15 [Video]

Covid update: India on herd immunity; Kolkata extends flight ban till Aug 15

From India stating that herd immunity is not a strategic option yet, to Kolkata extending flight ban, here are the top updates on coronavirus. Health Ministry on Thursday said herd immunity is not a..

Credit: HT Digital Content     Duration: 03:30Published
Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity [Video]

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity

The health ministry in its briefing on Covid-19 situation said that over 1 million people have recovered from Covid infection in the country. Addressing the media, Secretary in the Health Ministry..

Credit: HT Digital Content     Duration: 08:50Published
Moderna vaccine protects monkeys, next: 30,000 humans on trial | Oneindia News [Video]

Moderna vaccine protects monkeys, next: 30,000 humans on trial | Oneindia News

India welcomes first 5 Rafale jets at Ambala air base, all 36 to be delivered by end-2021; Mehbooba Mufti's daughter Iltija Mufti says 'mother won't blink first' on her detention in Kashmir; Rajasthan..

Credit: Oneindia     Duration: 02:53Published

Related news from verified sources

Hit by COVID cess, consumers downgrading to lower priced liquor

Hit by the steep price increase in wine, beer and spirits due to COVID cess, consumers in many states are downgrading to lower-priced alcoholic beverages,...
Mid-Day

COVID-19: Involve citizens in fight against coronavirus in Maharashtra, says Uddhav Thackeray

Maharashtra Chief Minister Uddhav Thackeray on Thursday said all cities in the state should set up 'corona vigilance committees',to involve participation of...
Mid-Day

World witnessing how one of the most successful battles against COVID-19 is being fought in India: Amit Shah

Union Home Minister Amit Shah on Sunday said that the whole world was appreciating India's successful fight against the COVID-19 pandemic. Speaking ahead of the...
Mid-Day


Tweets about this